Tim-3 is highly expressed in immune cells of liver, lung, breast, gastric and cervical cancer, and other solid tumors, and its expression intensity is also related to the progression and grade of hematological malignancies (25–31). This evidence concerns the gene HAVCR2 and hematologic disorder.